课题基金 / 基金详情

Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation

Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation
儿童腺病毒结膜炎的快速诊断检测:流行病学、临床和成本效益评估
批准号:
10647693
负责人:
Holly Frost
金额:
$15.24万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-10 至 2024-06-30
关键词:
18 year oldAccountingAcuteAcute ConjunctivitisAdenovirusesAdverse eventAdverse reactionsAgeAntibiotic ResistanceAntibioticsAntigensAntimicrobial ResistanceBacteriaBacterial InfectionsBiological AssayBiometryCaregiversChildChild CareChildhoodClinicClinicalClinical ResearchClinical SensitivityClinical effectivenessCommunicable DiseasesCommunitiesCommunity HealthComplicationConduct Clinical TrialsConjunctivitisCost Effectiveness AnalysisDataDay CareDecision TreesDiagnosisDiagnostic testsEconomic BurdenEnsureEpidemiologyEvaluationFDA approvedGoalsHealthHealth Care SectorHealth systemHealthcareHealthcare SystemsIncidenceInfectionK-Series Research Career ProgramsMentorsMentorshipModelingMulti-Institutional Clinical TrialMulticenter StudiesOutpatientsPatientsPediatricsPharmaceutical PreparationsPolymerase Chain ReactionPredictive ValuePrincipal InvestigatorRapid diagnosticsResearchResearch PersonnelSchoolsSensitivity and SpecificitySiteSpecificitySurveysSwabTestingTrainingTranslational ResearchUnited StatesUpper Respiratory InfectionsValidationViralViral ConjunctivitisVirusVirus DiseasesVisitWorkage groupantigen detectionantigen testarmcareerclinical carecomparative cost effectivenessconjunctivacost effectivecost effectivenesscost estimatecost-effectiveness evaluationdesigndetection platformdetection testdisease diagnosticdysbiosisexperiencefollow-upimprovedincremental cost-effectivenessinterestmicrobialmultidisciplinaryocular microbiomeparticipant enrollmentpoint of carepoint of care testingpoint-of-care diagnosticsprospectiverecruitsocialsocietal costssuccesssuperinfectiontransmission process

项目摘要

项目成果

Holly Frost的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Acute infectious conjunctivitis is one of the most common pediatric infections worldwide, however, the microbial causes of this infection are poorly understood. Though it has been estimated that up to 90% of conjunctivitis in children is viral in origin, over 80% of children with acute conjunctivitis are prescribed an ophthalmic antibiotic. This is a concern because incidence of antimicrobial resistant conjunctivitis is increasing, 8% of children have an adverse reaction to ophthalmic antibiotics, and prescription of ophthalmic antibiotics results in a large health care and social economic burden. Recently, an FDA approved point-of-care rapid antigen detection test for adenovirus conjunctivitis has become available. The test is $10.50, non-invasive, and can be completed in less than 15 minutes in the clinic setting. Implementation of this test may substantially reduce the use of ophthalmic antibiotics in children. The current utility of this test is limited, however, because: (1) data evaluating viral and bacterial causes of conjunctivitis in this age group are lacking; (2) rates of bacterial and viral concurrent infections are unknown; (3) the clinical sensitivity and specificity of the rapid point of care adenovirus test in children has not been assessed; and (4) cost effectiveness analysis for wide spread implementation of the test in pediatric settings has not been conducted. This proposal aims to meet the critical need to improve clinical care for children with conjunctivitis by (1) determining the viral and bacterial causes of conjunctivitis children; (2) clinically validating a rapid point of care adenovirus conjunctivitis test in children; and (3) estimating the percent reduction in unnecessary antibiotic prescriptions and cost-effectiveness of implementation of rapid adenovirus conjunctivitis diagnostic tests across health care systems. This project is the culmination of this candidate’s interest and experience in the validation and use of rapid infectious disease diagnostic tests to improve clinical care for children. The objective of this career development award is to develop this candidate into an independent principal investigator in clinical and translational research with expertise in the implementation and evaluation of infectious disease diagnostics in pediatrics. Mentorship, didactic coursework, seminars, and completion of the proposed study will address specific training needs of the investigator including training in the design and conduct of large-scale, multi-center clinical trials, advanced biostatistical analysis, and cost-effectiveness analysis. The candidate has assembled a multidisciplinary team of mentors and advisors with extensive research experience and topical expertise in the above realms to ensure her success in achieving the stated specific aims and career goals.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/jpids/piae010
发表时间: 2024
期刊: Journal of the Pediatric Infectious Diseases Society
影响因子: 3.2
作者: [Frost,HollyM, Keith,Amy, Fletcher,DanaR, Sebastian,Thresia, Dominguez,SamuelR, Kurtz,Melanie, Parker,SarahK, Wilson,MichaelL, Jenkins,TimothyC]
通讯作者: Jenkins,TimothyC
DOI: 10.1001/jamapediatrics.2021.6575
发表时间: 2022-05-01
期刊: JAMA PEDIATRICS
影响因子: 26.1
作者: [Frost, Holly M., Hersh, Adam L.]
通讯作者: Hersh, Adam L.
DOI: 10.1016/j.jpeds.2022.07.053
发表时间: 2022-12
期刊: JOURNAL OF PEDIATRICS
影响因子: 5.1
作者: [Frost, Holly M., Bizune, Destani, Gerber, Jeffrey S., Hersh, Adam L., Hicks, Lauri A., Tsay, Sharon, V]
通讯作者: Tsay, Sharon, V
DOI: 10.1016/j.jaapos.2021.12.008
发表时间: 2022-06
期刊: JOURNAL OF AAPOS
影响因子: 1.6
作者: [Sebastian, Thresia, Frost, Holly M.]
通讯作者: Frost, Holly M.
21
    RELAX: Reducing Length of Antibiotics For Children With Ear Infections
    RELAX: Reducing Length of Antibiotics For Children With Ear Infections
    Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation
    Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation
    海外基金